Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer
Chan S, Frimodt-Moller B, Vaury A, Carrasco E, Jones A, Harrison M, Antón A, Mayordomo J, Kreienberg R, du Bois A, Llombart A, Lluch A, Schneeweiss A, Tubiana-Hulin M, Delozier T, Huober J, Romieu G, Fumoleau P. Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:1753-60.
Apr 10, 2009
Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer
Apr 10, 2009
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009; 27:1753-60
Chan Stephen, Frimodt-Moller Bente, Vaury A Thareau, Carrasco Eva, Jones Alison, Harrison Mark, Antón Antonio, Mayordomo Jose Ignacio, Kreienberg Rolf, du Bois Andreas, Llombart Antonio, Lluch Ana, Schneeweiss Andreas, Tubiana-Hulin Michele, Delozier Thierry, Huober Jens, Romieu Gilles, Fumoleau Pierre
more
